Semisynthetic resorbable materials from hyaluronan esterification

Biomaterials

Volumn 19, Issue 23, 1998, Pages 2101-2127

  Campoccia, Davide ^a   Doherty, Patrick ^c   Radice, Marco ^b   Brun, Paola ^b   Abatangelo, Giovanni ^b   Williams, David F ^c  

^a Fidia Advanced Biopolymers   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Artificial cartilage; Artificial skin; Biocompatiblity; Cell adhesion; Degradable biopolymers; Degradable scaffolds; Drug release; Hyaluronan; Hyaluronan esters; Hydrogels; Leukocyte activation; Resorbable materials; Tissue engineering

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BIOMEDICAL ENGINEERING; CHEMICAL MODIFICATION; ESTERIFICATION; HYDRATION; HYDROGELS; PHYSICAL PROPERTIES; TISSUE;

ARTIFICIAL CARTILAGE; ARTIFICIAL SKIN; CELL ADHESION; DEGRADABLE SCAFFOLDS; DRUG RELEASE; HYALURONAN; LEUKOCYTE ACTIVATION; SEMISYNTHETIC RESORBABLE MATERIALS;

BIOPOLYMERS;

BIOMATERIAL; BIOPOLYMER; CALCITONIN; CARBOXYL GROUP; CHLORPROMAZINE; COMPLEMENT; ESTER; HYALURONIC ACID DERIVATIVE; INSULIN; METHYLPREDNISOLONE; STEROID;

ARTIFICIAL SKIN; BIOCOMPATIBILITY; CARTILAGE; CELL ADHESION; DEGRADATION; DRUG DELIVERY SYSTEM; ESTERIFICATION; FIBRINOLYSIS; HUMAN; HYDROGEL; INTRANASAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; MESENCHYME; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REVIEW; SHEEP;

OVIS ARIES;

EID: 0032403155     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(98)00042-8     Document Type: Review

References (174)

1. [1] Böstman OM, Current concepts review. Absorbable implants for the fixation of fractures. J Bone Jt Surg 1991:148-52.
2. [2] Ranade VV. Drug delivery systems, 3B. Role of polymers in drug delivery. J Clin Pharmacol 1990;30:107-20.
3. [3] Hutmacher D, Hurzeler MB, Schliephake H. A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR. Int J Oral Maxillofac Implants 1996;11(5):667-78.
4. [4] Freed LE, Vunjak-Novakovic G, Biron RJ, Eagles DB, Lesnoy DC, Barlow SK, Langer R. Biodegradable polymer scaffolds for tissue engineering. Bio/Technol 1994;12:689-95.
5. [5] Bell E. Strategy for the selection of scaffolds for tissue engineering. Tissue Engng 1995;1(2):163-79.
6. [6] Sittinger M, Bujia J, Rotter N, Reitzel D, Minuth WW, Burmester GR. Tissue engineering and autologous transplant formation: pratical approaches with resorbable biomaterials and new cell culture techniques. Biomaterials 1996;17(3):237-42.
7. [7] Van Wachem PB, van Luyn MJA, Nieuwenhuis P, Koerten HK, Olde Damink L, Ten Hoopen H, Feijen J. In vivo degradation of processed dermal sheep collagen evaluated with transmission electron microscopy. Biomaterials 1991;12:215-23.
8. [8] Hunt JA, Stella VJ, Topp EM. Characterization of polymeric films prepared from ester derivatives of hyaluronic acid. In: Proceedings of the 3rd International Workshop on Recent Developments in Industrial Polysaccharides: Biomedical and Biotechnological Advances. Trieste, 24-26 October 1988:55-61.
9. [9] Rastrelli A, Beccaro M, Biviano F, Calderini G, Pastorello A. Hyaluronic acid esters, a new class of semisynthetic bio-polymers: chemical and physico-chemical properties. Clin Implant Mater 1990;9:199-205.
10. [10] Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;6(7): 2397-404.
11. [11] Engström-Laurent A, Laurent TC. Hyaluronan as a clinical marker. In: Clinical impact of bone and connective tissue markers. New York: Academic Press Ltd., 1989:235-52.
12. .) radicals is dependent on hyaluronan molecular mass. Cell Biochem Function 1994;12:281-8.
13. [13] Abatangelo G, O'Regan M. Hyaluronan: biological role and function in articular joints. European J Rheumatol Inflammation 1995;15(1):9-16.
14. [14] Partsch G, Schwarzer Ch, Neumüller J, Dunky A, Petera P, Bröll H, Ittner G, Jantsch S. Modulation of the migration and chemotaxis of PMN cells by hyaluronic acid. Zeitschrift für Rheumatologie 1989;48:123-8.
15. [15] King SR, Hickerson WL, Proctor KG, Newsome AM. Beneficial actions of exogenous hyaluronic acid on wound healing. Surg 1991;109(1):76-91.
16. [16] West DC, Kumar S. Hyaluronan and angiogenesis. In: Evered D, Whelan J, editors. The biology of hyaluronan. Ciba Foundation Symposium. UK: Chichester, 1989:187-207.
17. [17] van Wachem PB, van Luyn MJA, Koerten HK, Olde Damink L, Ten Hoopen H, Feijen J, Nieuwenhuis P. In vivo degradation of sheep collagen evaluated with transmission electron microscopy. Biomaterials 1991;12:215-23.
18. [18] Balazs EA, Leshchiner EA. Hyaluronan, its crosslinked derivative - Hylan - and their medical applications. In: Inagaki, Phillips, editors. Proceedings of the Nisshinbo International Conference on Cellulosics Utilization in the Near Future. New York: Elsevier Applied Science Publ., 1989:233-41.
19. [19] Kuo JW, Swann DA, Prestwich GD. Water-insoluble derivatives of hyaluronic acid and their method of preparation and use. US Patent 5356883, 1994.
20. [20] Maison T, Lindqvist B. Crosslinked hyaluronate gels, their use and method for producing them. PCT WO 90/09401.
21. [21] De Belder AN, Malson T. Gel for preventing adhesion between body tissues and process for its production. PCT WO 86/00912.
22. [22] Matsuda T, Moghaddam MJ, Sakurai K. Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof. US Patent 5462976, 1995.
23. [23] Pouyani T, Prestwich GD. Functionalized derivatives of hyaluronic acid. PCT WO 95/15168.
24. [24] Rhee WM, Berg RA. Glycosaminoglycan-synthetic polymer conjugates. US Patent 5510121, 1996.
25. [25] Mensitieri M, Ambrosio L, Nicolais L, Bellini D, O'Regan M. Viscoelastic properties modulation of a novel autocrosslinked hyaluronic acid polymer. J Mater Sci: Mater Med 1996;7:695-8.
26. [26] Benedetti L, Bellini D, Renier D, O'Regan M. Chemical modification of hyaluronan. In: Novel biomaterials based on hyaluronic acid and its derivatives. Williams DF, editor. Proceedings of a Workshop held at the Annual Meeting of the European Society for Biomaterials. Pisa, Italy, 1994:20-9.
27. [27] Burns JW, Walts AE. Water insoluble derivatives of hyaluronic acid. US Patent 5017229, 1991.
28. [28] Barbucci R, Magnani A, Baszkin A, Da Costa ML, Bauser H, Hellwig G, Martuscelli E, Cimmino S. Physico-chemical surface characterization of hyaluronic acid derivatives as a new class biomaterials. J Biomater Sci Polym Edn 1993;4(3):245-73.
29. [29] Hunt JA, Joshi HN, Stella VJ, Topp EM. Diffusion and drug release in polymer films prepared from ester derivatives of hyaluronic acid. J Controlled Release 1990;12:159-69.
30. [30] Joshi HN, Topp EM. Hydration in hyaluronic acid and its esters using differential scanning calorimetry. Int J Pharmaceutics 1992;80:213-25.
31. [31] Iannace S, Ambrosio L, Nicolais L, Rastrelli A, Pastorello A. Thermomechanical properties of hyaluronic acid-derived products. J Mater Sci: Mater Med 1992;3:59-64.
32. [32] Cortivo E, Brun P, Rastrelli A, Abatangelo G. In vitro studies on biocompatibility of hyaluronic acid esters. Biomaterials 1991; 12:727-30.
33. [33] Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983;65:55-63.
34. [34] Srivastava S, Gorham SD, French DA, Shivas AA, Courtney JM. In vivo evaluation and comparison of collagen, acetylated collagen and collagen/glycosaminoglycan composite films and sponges as candidate biomaterials. Biomaterials 1990; 11:155-61.
35. [35] Lydon MJ, Minett TW, Tighe BJ. Cellular interactions with synthetic polymer surfaces in culture. Biomaterials 1985; 6:396-402.
36. [36] Campoccia D, Hunt JA, Doherty PJ, Zhong SP, Callegaro L, Benedetti, Williams DF. Human neutrophil chemokinesis and polarization induced by hyaluronic acid derivatives. Biomaterials 1993;14(15):1135-9.
37. [37] Allen RA, Traynor AE, Omann GM, Jesaitis AJ. The chemotactic peptide receptor. In: Curnutte JT, editor. Hematology/Oncology Clinics of North America, vol. 2. London: W.B. Saunders, 1988:33-60.
38. [38] Meager A, Leung H, Woolley J. Assays for tumour necrosis factor and related cytokines. J Immunol Meth 1989;116:1-17.
39. [39] Tracey WR, Tse J, Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Therap 1995;272(3):1011-5.
40. [40] Rent R, Ertel N, Eisenstein R, Gewurz H. Complement activation by interaction of polyanions and polycations. I. Heparine-protamine induced consumption of complement. J Immunol 1975;114(1):120-4.
41. [41] Cooper NR. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 1985;37:151-216.
42. [42] Kazattchkine MD, Carreno MP. Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials 1988;9:30-5.
43. [43] Roitt IM, Brostoff J, Male DK. Complement. In: Immunology. Roitt IM, Brostoff J, Male DK, editors. London: Churchill Livingstone, 1989:13.1-.16.
44. [44] Le Boeuf RD, Roja RH, Fuller GM, Weigel PH. Human fibrinogen specifically binds hyaluronic acid. J Biol Chem 1986; 261:12586-92.
45. [45] Scully MF, Fakkar VV, Goodwin A, O'Regan M. Inhibition of fibrinolytic activity by hyaluronan and its alcohol ester derivatives. Thrombosis Res 1995;78(3):255-8.
46. [46] Bergsma JE, Bruijn WC, Rozema FR, Bos RRM, Boering G. Late degradation tissue response to poly(L-lactide) bone plates and screws. Biomaterials 1995;16:25-31.
47. [47] Beumer GJ, van Blitterswijk CA, Ponec M. Degradative behaviour of polymeric matrices in (sub)dermal and muscle tissue of the rat: a quantitative study. Biomaterials 1994;15(7):551-9.
48. [48] Benedetti L, Cortivo R, Berti T, Pea F, Mazzo M, Moras M, Abatangelo G. Biocompatibility and biodegradation of different hyaluronan derivatives (HYAFF) implanted in rats. Biomaterials 1993;14(15):1135-9.
49. [49] Campoccia D, Hunt JA, Doherty PJ, Zhong SP, O'Regan M, Benedetti L, Williams F. Quantitative assessment of the tissue response to films of hyaluronan esters. Biomaterials 1996; 17(10):963-75.
50. [50] Wragg MS, Brooks PN, Doleman N. Biodegradation/toxicity study in the rat. Safepharm Ltd. Project no. 551/27. 1996:1-158.
51. [51] Benedetti L, Topp EM, Stella VJ. Microspheres of hyaluronic acid esters - fabrication methods and in vitro hydrocortisone release. J Controlled Release 1990;13:33-41.
52. [52] Benedetti L, Joshi HN, Goei L, Hunt JA, Callegaro L, Stella VJ, Topp EM. Dosage forms from polymeric prodrugs: hydrocortisone esters of hyaluronic acid. New Polymeric Matter 1991;3(1):41-8.
53. [53] Joshi HN, Stella VJ, Topp EM. Drug release from membranes of hyaluronic acid and its esters. J Controlled Release 1992; 20:109-22.
54. [54] Rajewski LG, Stinnett AA, Stella VJ, Topp EM. Enzymic and non-enzymic hydrolysis of a polymeric prodrug: hydrocortisone esters of hyaluronic acid. Int J Pharmaceutics 1992;82:205-13.
55. [55] Hume LR, Lee HK, Benedetti L, Sanzgiri, Toop EM, Stella VJ. Ocular sustained delivery of prednisolone using hyaluronic acid benzyl ester films. Int J Pharmaceutics 1994;111:295-8.
56. [56] Kyyronen K, Hume L, Benedetti L, Urtti A, Topp E, Stella V. Methyl-prednisolone esters of hyaluronic acid in ophthalmic drug delivery. Int J Pharmaceutics 1992;80:161-9.
57. [57] Payan E, Jouzeau JY, Lapicque F, Bordji K, Simon G, Gillet P, O'Regan M, Netter P. In vitro drug delivery release from HYC 141, a corticosteroid ester of high molecular weight hyaluronan. J Controlled Release 1995;34:145-53.
58. [58] Papini D, Stella VJ, Topp EM. Diffusion of macromolecules in membranes of hyaluronic acid esters. J Controlled Release 1993; 27:47-57.
59. [59] Ghezzo E, Benedetti L, Rochira M, Biviano F, Callegaro L. Hyaluronan derivative microspheres as NGF delivery devices: preparation methods and in vitro release characterization. Int J Pharmaceutics 1992;87:21-9.
60. [60] Illum L, Farraj NF, Fisher AN, Gill I, Miglietta M, Benedetti L. Hyaluronic acid ester microspheres as a nasal delivery system for insulin. J Controlled Release 1994;29:133-41.
61. [61] Richardson J, Ramires PA, Miglietta MR, Rochira M, Bacelle L, Callegaro L, Benedetti L. Novel vaginal delivery systems for calcitonin. I. Evaluation of HYAFF/calcitonin microspheres in rats. Int J Pharmaceutics 1995;115:9-15.
62. [62] Bonucci E, Ballanti P, Ramires PA, Richardson J, Benedetti L. Prevention of ovariectomy osteopenia to rats after vaginal administration of HYAFF 11 microspheres containing salmon calcitonin. Calcif Tissue Int 1995;56:274-9.
63. [63] Pritchard K, Lansley AB, Martin GP, Helliwell M, Marriott C, Benedetti L. Evaluation of the bioadhesive properties of hyaluronan derivatives: detachment rate and mucociliary transport rate. Int J Pharmaceutics 1996;129:137-45.
64. [64] Pouyani T, Prestwich GD. Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. Bioconjugate Chem 1994;5:339-47.
65. [65] Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6.
66. [66] Yannas IV. Applications of ECM analogs in surgery. J Cell Biochem 1994;56:188-91.
67. [67] Srivastava S, Gorham SD, French DA, Shivas AA, Courtney JM. In vivo evaluation and comparison of collagen, acetylated collagen and collagen/glycosaminoglycan composite films and sponge as candidate biomaterials. Biomaterials 1990;11:155-61.
68. [68] Cooper ML, Hansbrough JF, Spielvogel RL, Cohen R, Bartel RL, Naughton G. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991;12:243-8.
69. [69] Blayney AW, Williams KR, Erre JP, Lesser TH, Portmann M. Problems in alloplastic middle ear reconstruction. Acta Otolaryngol Stockh 1992;112:322-7.
70. [70] Beumer GJ, van Blitterswijk CA, Bakker D, Ponec M. Cell-seeding and in vitro biocompatibility evaluation of polymeric matrices of PEO/PBT copolymers and PLLA. Biomaterials 1993;14:598-604.
71. [71] Bush RB. A bibliography of monographic works on biomaterials and biocompatibility: update. J Biomed Mater Res 1996; 33:107-13.
72. [72] Matouskova E, Vogtova D, Konigova R. A recombined skin composed of human keratinocytes cultured on cell-free pig dermis. Burns 1993;19:118-23.
73. [73] Rennekampff HO, Kiessig V, Hansbrough JF. Current concepts in the development of cultured skin replacements. J Surg Res 1996;62:288-95.
74. [74] Abatangelo G, Brun P, Cortivo R. Hyaluronan (Hyaluronic acid): an overview. In: Williams DF, editor. Novel biomaterials based on hyaluronic acid and its derivatives. Proceedings of a Workshop held at the Annual Meeting of the European Society for Biomaterials, Pisa, Italy, 1994:8-18.
75. [75] Toole BP, Munaim SI, Welles S, Knudson CB. Hyaluronate cell interaction and growth factor regulation of hyaluronate synthesis during limb development. In: CIBA Found Symp. 143, The biology of hyaluronan. Chichester: Wiley, 1989:138-45.
76. [76] Maleski MP, Knudson CB. Matrix accumulation and retention in embryonic cartilage and in vitro chondrogenesis. Conn Tissue Res 1996;34(1):75-86.
77. [77] Mast BA, Diegelmann RF, Krummel TM, Cohen IK. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 1993;13:441-6.
78. [78] Rooney P, Kumar S. Inverse relationship between hyaluronan and collagens in development and angiogenesis. Differentiation 1993;54:1-9.
79. [79] Gotz W, Osmers R, Herken R. Localisation of extracellular matrix components in the embryonic human notochord and axial mesenchyme. J Anat 1995;186(1):111-21.
80. [80] Pitsillides AA, Archer CW, Prehm P, Bayliss MT, Edwards JC. Alterations in hyaluronan synthesis during developing joint cavitation. J Histochem Cytochem 1995;43:263-73.
81. [81] Wheatley SC, Isacke CM, Crossley PH. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 1993;119:295-306.
82. [82] Brown JJ, Papaioannou VE. Ontogeny of hyaluronan secretion during early mouse development. Development 1993;117:483-92.
83. [83] Krenn V, Brand-Saberi B, Wachtler F. Hyaluronic acid influences the migration of myoblasts within the avian embryonic wing bud. Am J Anat 1991;192:400-6.
84. [84] Peterson PE, Pow CS, Wilson DB, Hendrickx AG. Distribution of extracellular matrix components during early embryonic development in the macaque. Acta Anat Basel 1993;146:3-13.
85. [85] Kujawa MJ, Caplan AI. Hyaluronic acid bonded to cell-culture surfaces stimulates chondrogenesis in stage 24 limb mesenchyme cell cultures. Dev Biol 1986;114:504-18.
86. [86] Moriarty KP, Crombleholme TM, Gallivan EK, O'Donnell C. Hyaluronic acid-dependent pericellular matrices in fetal fibroblasts: implication for scar-free wound repair. Wound Rep Reg 1996;4:346-52.
87. [87] Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J 1993;7:1233-41.
88. [88] Oksala O, Salo T, Tammi R, Hakkinen L, Jalkanen M, Inki P, Larjava H. Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem 1995;43:125-35.
89. [89] Siebert JW, Burd AR, McCarthy JG, Weinzweig J, Ehrlich HP. Fetal wound healing: a biochemical study of scarless healing. Plast Reconstr Surg 1990;85:495-502.
90. [90] Cortivo R, De Galateo A, Castellani I, Brun P, Giro MG, Abatangelo G. Hyaluronic acid promotes chick embryo fibroblast and chondroblast expression. Cell Biol Int Rep 1990;14(2):111-22.
91. [91] Shepard S, Becker H, Hartmann JX. Using hyaluronic acid to create a fetal-like environment in vitro. Ann Plast Surg 1996;36:65-9.
92. [92] Doillon CJ, Wasserman AJ, Berg RA, Silver FH. Behaviour of fibroblasts and epidermal cells cultivated on analogues of extracellular matrix. Biomaterials 1988;9:91-6.
93. [93] Huang-Lee LLH, Nimni ME. Crosslinked CNBr-activated hyaluronan-collagen matrices: effects on fibroblast contraction. Matrix Biology 1994;14:147-57.
94. [94] Brekke JH. A rational delivery of osteoinductive proteins. Tissue Engineering 1996;2(2):97-114.
95. [95] Zhong SP, Campoccia D, Doherty PJ, Williams, RL, Benedetti L, Williams DF. Biodegradation of hyaluronic acid derivatives by hyaluronidase. Biomaterials 1994;15(5):359-65.
96. [96] Campoccia D. Aspects of the biocompatibility of hyaluronan derivatives. PhD Thesis, University of Liverpool, UK, 1996.
97. [97] Sittinger M, Reitzel D, Dauner M, Hierlemann H, Hammer C, Kastenbauer E, Planck H, Burmester GR, Bujia J. Resorbable polyesters in cartilage engineering: affinity and biocompatibility of polymer fiber structures to chondrocytes. J Biomed Mater Res 1996;33:57-63.
98. [98] Cuono CB, Langdon RC, Birchall N, Battelbort S, McGuire J. Composite autologous allogenic skin replacement and clinical application. Plast Reconstr Surg 1987;80:626-35.
99. [99] Hansbrough JF, Morgan J, Greenleaf G. Advances in wound coverage using cultured cell technology. Wounds 1993;5(4):174-94.
100. [100] Boyce ST, Goretsky MJ, Greenhalgh DG, Kagan RJ, Rieman, Warden GD. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg 1995;222:743-52.
101. [101] McKay I, Woodward B, Wood K, Navsaria HA, Hoekstra H, Green C. Reconstruction of human skin from glycerol-preserved allodermis and cultured keratinocyte sheets. Burns 1994; 20(Suppl 1):S19-22.
102. [102] Marshall L, Ghosh MM, Boyce SG, MacNeil S, Freedlander E, Kudesia G. Effect of glycerol on intracellular virus survival:implications for the clinical use of glycerol-preserved cadaver skin. Burns I 1995;21:356-61.
103. [103] Phillips TJ. Cultured skin grafts. Arch Dermatol 1988; 124:1035-8.
104. [104] Leigh IM, Watt FM. The culture of human epidermal keratinocytes. In: Leigh IM, Lane B, Watt FM, editors. The keratinocyte handbook. Cambridge: Cambridge University Press, 1994:43-51.
105. [105] O'Connor NE, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981;1:75-8.
106. [106] Compton CC, Gill JM, Bradford DA, Regauer S, Gallico GG, O'Connor NE. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. Lab Invest 1989;60:600-12.
107. [107] Compton CC. Cultured epithelial autografts for burn wound resurfacing: review of observations from an 11 year biopsy study. Wounds 1996;8:125-33.
108. [108] Leigh IM. Keratinocyte autografting, allografting and wound healing. In: Leigh IM, Lane B, Watt FM, editors. The keratinocyte handbook. Cambridge: Cambridge University Press, 1994:503-11.
109. [109] Hultman CS, Brinson GM, Siltharm S, Deserres S, Cairns BA, Peterson HD, Meyer AA. Allogeneic fibroblasts used to grow cultured epidermal autografts persist in vivo and sensitize the graft recipient for accelerated second set rejection. J Trauma Inj Infect Crit Care 1996;41:51-8.
110. [110] Phillips TJ, Pachas W. Clinical trial of cultured autologous keratinocyte grafts in the treatment of long-standing pressure ulcers. Wounds 1994;6:113-9.
111. [111] Limova M, Mauro T. Treatment of leg ulcers with cultured epithelial autografts: treatment protocol and five year experience. Wounds 1995;7:170-80.
112. [112] Rennekampff HO, Hansbrough JF, Kiessig V, Abiezzi S, Woods V Jr. Wound closure with human keratinocytes cultured on a polyurethane dressing overlaid on a cultured human dermal replacement. Surg 1996;120:16-22.
113. [113] Andreassi L, Casini L, Trabucchi E, Diamantini S, Rastrelli A, Donati L, Tenchini ML, Malcovati M. Human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid suitable for grafting. Wounds 1991;3:116-26.
114. [114] Zacchi V, Soranzo C, Cortivo R, Radice M, Brun P, Abatangelo G. In vitro engineering of living human skin. J Biomed Mater Res 1997;submitted.
115. [115] Myers SR, Navsaria HA, Grady J, Soranzo C, Sanders R, Green C, Leigh IM. A hyaluronic acid membrane delivery system for cultured keratinocytes: clinical 'take' rates in a porcine keratodermal model. Br J Plastic Surg 1996;submitted.
116. [116] Donati L, Veronesi AM, Garbin S, Ordanini MN, Ferrone MP, Falcone L, Marazzi M. In vitro development and clinical application in burn patients of keratinocytes cultured on a hyaluronic acid ester membrane. In: Williams DF, editor. Novel biomaterials based on hyaluronic acid and its derivatives. Proceedings of a Workshop held at the Annual Meeting of the European Society for Biomaterials, Pisa, Italy, 1994: 52-61.
117. [117] Donati L, Marazzi M, Veronesi AM, Ordanini MN, Falcone L, Ferrone M, Mauri S. Treatment of cuteaneous wound with cultured human keratinocytes on hyaluronic acid membrane. Wound Rep Regen 1995;3:363.
118. [118] Navsaria HA, Myers SR, Soranzo C, Kangesu T, Cussons P, Leigh IM. Laserskin®: in vitro characterisation of delivery system for cultured keratinocytes and its clinical application. FATB - 5th International Conference on Tissue Banking, Berlin, Germany, 11-15 September 1996.
119. [119] Milthorpe BK. Xenografts for tendon and ligament repair. Biomaterials 1994;15:745-52.
120. [120] Rogers JJ, Young HE, Adkinson LR, Lucas PA, Black AC. Differentiation factors induce expression of muscle, fat, cartilage, and bone in a clone of mouse pluripotent mesenchymal stem cells. Am Surg 1995;61(3):231-6.
121. [121] Ishibashi K, Matsuda T. Reconstruction of a hybrid vascular graft hierarchically layered with three cell types. ASAIO J 1994;40:M284-90.
122. [122] Eppley BL, Summerlin DJ, Sadove AM. A potential biomaterial composite for dermal and subcutaneous augmentation. Ann Plast Surg 1994;32:463-8.
123. [123] Burres SA. Recollagenation of acne scars. Dermatol Surg 1996;22:364-7.
124. [124] Lopez-Valle CA, Auger FA, Rompre P, Bouvard V, Germain L. Peripheral anchorage of dermal equivalents. Br J Dermatol 1992;127:365-71.
125. [125] Huang-Lee LL, Nimni ME. Crosslinked CNBr-activated hyaluronan-collagen matrices: effects on fibroblast contraction. Matrix Biol 1994;14:147-57.
126. [126] Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. J Immunol Meth 1986;89:271-7.
127. [127] MacKenzie I. Epithelial-mesenchymal interactions in the development and maintenance of epithelial tissues. In: Leigh I, Watt FM, editors. The keratinocyte handbook. Cambridge: Cambridge University Press, 1994:243-57.
128. [128] Coulomb B, Lebreton C, Dubertret L. Influence of human dermal fibroblasts on epidermalization. J Invest Dermatol 1989; 92:122-5.
129. [129] Krejci NC, Cuono CB, Langdon RC, McGuire J. In vitro reconstitution of skin: fibroblasts facilitate keratinocyte growth and differentiation on acellular reticular dermis. J Invest Dermatol 1991;97:843-8.
130. [130] Fusenig NE. Epithelial-mesenchymal interactions regulate keratinocyte growth and differentiation in vitro. In: Leigh I, Lane B, Watt FM, editors. The keratinocyte handbook. Cambridge: Cambridge University Press, 1994:71-94.
131. [131] Dubertret L, Coulomb B. Organogenese cutanee in vitro. Bull Acad Natl Med 1995;179:1121-30.
132. [132] Boyce ST, Goretsky MJ, Greenhalgh DG, Kagan RJ, Rieman MT, Warden GD. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg 1995;222:743-52.
133. [133] Cooper ML, Hansbrough JF. Advantages of a dermal component in designing a cultured skin substitute. J Cell Biochem 1990;E14:251.
134. [134] Hansbrough JF, Morgan J, Greenleaf G. Advances in wound coverage using cultured cell technology. Wounds 1993;5(4):174-94.
135. [135] Heck E, Bergstresser P, Baxter C. Composite skin graft: frozen dermal allografts support the engraftment and expansion of autologous epidermis. J Trauma 1985;25:106-12.
136. [136] Medalie DA, Eming SA, Tompkins RG, Yarmush ML, Krueger GG, Morgan JR. Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. J Invest Dermatol 1996; 107:121-7.
137. [137] Rennekampff HO, Kiessig V, Hansbrough JF. Current concepts in the development of cultured skin replacements. J Surg Res 1996;62:288-95.
138. [138] Sabolinski ML, Alvarez O, Auletta M, Mulder G, Parenteau NL. Cultured skin as a smart material for healing wounds: experience in venous ulcers. Biomaterials 1996;17:311-20.
139. [139] Pistoor FHM, Rambukkana A, Kroezen M, Lepoittevin JP, Bos JD, Kapsenberg ML, Das PK. Novel predictive assay for contact allergens using human skin expiant cultures. Am J Pathol 1996;149:337-43.
140. [140] Abatangelo G, Radice M, Zacchi V, Cortivo R. Integrin expression of keratinocytes cultivated on hyaluronan derived biomaterials. Wound Rep Regen 1995;3:80.
141. [141] Shortkroff S, Barone L, Hsu H-P, Wrenn C, Gagne T, Chi T, Breinan H, Minas T, Sledge CB, Tubo R, Spector M. Healing of chondral and osteochondral defects in a canine model: the role of cultured chondrocytes in regeneration of articular cartilage. Biomaterials 1996;17:147-54.
142. [142] Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331(14):889-95.
143. [143] Mankin HJ. Chrondrocyte transplantation - one answer to an old question. N Engl J Med 1994;331(14):940-1.
144. [144] Messner K, Gillquist J. Cartilage repair. Acta Orthop Scand 1996;67(5):523-9.
145. [145] Bean JK, Verwoerd-Verhoef HL, Verwoerd CD. Reconstruction of the anterior laryngeal wall with a composite graft of demineralized bovine bone matrix and autogenous perichondrium. An experimental study in adult rabbits. ORL J Othorhinolaryngol Relat Spec 1994;56:224-9.
146. [146] Freed LE, Grande DA, Lingbin Z, Emmanual J, Marquis JC, Langer R. Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds. J Biomed Mater Res 1994;28:891-9.
147. [147] Iyoda K, Miura T, Nogami H. Repair of bone defect with cultured chondrocytes bound to hydroxyapatite. Clin Orthop Rel Res 1993;288:287-93.
148. [148] Fujisato T, Sajiki T, Liu Q, Ikada Y. Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte seeded collagen sponge scaffold. Biomaterials 1996;17:155-62.
149. [149] Robinson D, Halperin N, Nevo Z. Regenerating hyaline cartilage in articular defects of old chickens using implants of embryonal chick chondrocytes embedded in a new natural delivery substance. Calcif Tissue Int 1990;46:246-53.
150. [150] Abatangelo G, Cortivo R, Radice M, Zacchi V. Cultured cartilage on scaffolds made up by hyaluronan ester derivatives. Wound Rep Reg 1995;3:373.
151. [151] Cortivo R, Radice M, Brun P, Zacchi V, Abatangelo G. Chondrocyte cultures on semisynthetic polymers made up by hyaluronan (hyaluronic acid) esters. 21st Annual Meeting of the Society for Biomaterials 1995:401.
152. [152] Vacanti CA, Langer R, Schloo B, Vacanti JP. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg 1991;88:753-9.
153. [153] Paige KT, Vacanti CA. Engineering new tissue: formation of neo-cartilage. Tissue engineering 1995;1(2):97-106.
154. [154] Freed LE, Marquis JC, Nohria A, Emmanual J, Mikos AG, Langer R. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mat Res 1993;27:11-23.
155. [155] Aigner J, Tegeler J, Hutzler P, Campoccia D, Pavesio A, Naumann A, Bujia J. Cartilage tissue-engineering with a novel non-woven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mat Res, submitted.
156. [156] Grigoriadis AE, Heersche JNM, Aubin JE. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J Cell Biol 1988;106:2139-51.
157. [157] Young HE, Mancini ML, Wright RP, Smith JC, Black AC Jr, Reagan CR, Lucas PA. Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dynamics 1995; 202:137-44.
158. [158] Rogers JJ, Young HE, Adkinson LR, Lucas PA, Black AC. Differentiation factors induce expression of muscle, fat, cartilage, and bone in a clone of mouse pluripotent mesenchymal stem cells. Am Surg 1995;61(3):231-6.
159. [159] Caplan AI. Mesenchymal stem cells. J Orthop Res 1991:641-50.
160. [160] Caplan AI. The mesengenic process. Bone Rep Reg 1994; 21(3):429-35.
161. [161] Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995;16:557-64.
162. [162] Kasugai S, Todescan R Jr, Nagata T, Yao KL, Butler WT, Sodek J. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype. J Cell Physiol 1991;147:111-20.
163. [163] Rogers GJ, Milthorpe BK, Schindhelm K, Howlett CR, Roe S. Shielding of augmented tendon-tendon repair. Biomaterials 1995;16:803-7.
164. [164] Dixon KP, Murphy RW, Southerland SS, Young HE, Lucas PA. Recombinant human bone morphogenetic proteins-2 and -4 induce several mesenchymal phenotypes in culture. Wound Rep Reg 1996;4:374-80.
165. [165] Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldeberg VM. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Jt Surg 1994;76-A(4):579-92.
166. [166] Butnariu-Ephrat M, Robinson D, Mendes DG, Halperin N, Nevo Z. Resurfacing of goat articular cartilage by chondrocytes derived from bone marrow. Clin Orthop Relat Res 1996; 330:234-43.
167. [167] Tona A, Valentini RF. Derivatized hyaluronic acid films support mesenchymal stem cell attachment and proliferation. 5th World Biomaterials Congress, Toronto, 1996;2:849.
168. [168] Solchaga LA, Arm D, Johnstone B, Yoo JU, Awadallah A, Goldberg VM, Caplan AI. HYAFF-11: a new delivery vehicle for tissue engineering. Abstract submitted to the 44th Annual Meeting. Orthopaedic Research Society, New Orleans, 1998.
169. [169] Cassinelli C, Morra M, Renier R, Pavesio A. Anti-adhesive surfaces through hyaluronan coatings. Med Dev Technol, in press.
170. [170] In: Williams DF, editor. Definitions in biomaterials. Progress in biomedical engineeering. Oxford: Elsevier, 1987;4:67.
171. [171] Kazattchkine MD, Carreno MP. Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials 1988;9:30-5.
172. [172] Janatova J, Cheung AK, Parker CJ. Biomedical polymers differ in their capacity to activate complement. Complement Inflammation 1991;8:61-9.
173. [173] Glass JR, Dickerson KT, Stecker K, Polarek JW. Characterization of a hyaluronic acid-Arg-Gly-Asp peptide cell attachment matrix. Biomaterials 1996;17:1101-8.
174. [174] Peppas NA, Langer R. New challenges in biomaterials. Science 1994;263:1715-20.